Schedule 13D ownership disclosure

WEREWOLF THERAPEUTICS INC

Security class unavailable · CUSIP: 95075A107

Event date: 2021-05-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
10.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-21-162185
Form type
SC 13D
Filer
MPM BioVentures 2014, L.P.
CIK
CIK 1609492
Filed
May 14, 2021
Reporting period
May 04, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub